Literature DB >> 3287042

Anxiety and depression in substance abuse: clinical implications.

H R Kranzler1, N R Liebowitz.   

Abstract

Accurate diagnosis in patients presenting with anxiety and/or depressive symptoms requires that the contribution of substance abuse be carefully considered. When chemical dependence is identified, detoxification may be all that is necessary. However, if indicated, specific treatment of the mood or anxiety disorder may reduce substance use as well.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3287042     DOI: 10.1016/s0025-7125(16)30749-0

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  4 in total

1.  Substance use disorders in individuals with body dysmorphic disorder.

Authors:  Jon E Grant; William Menard; Maria E Pagano; Christina Fay; Katharine A Phillips
Journal:  J Clin Psychiatry       Date:  2005-03       Impact factor: 4.384

2.  Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons.

Authors:  Michael D Stein; Debra S Herman; Malyna Kettavong; Patricia A Cioe; Peter D Friedmann; Tahir Tellioglu; Bradley J Anderson
Journal:  J Subst Abuse Treat       Date:  2010-07-03

3.  Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates.

Authors:  G F Longstreth; G Wolde-Tsadik
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

Review 4.  The association of alcoholism and anxiety.

Authors:  K T Brady; R B Lydiard
Journal:  Psychiatr Q       Date:  1993
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.